Skip to main content
SpringerLink
Log in

Medication adherence: A key factor in effective management of rosacea

  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

Rosacea is a chronic condition associated with relapses. Unsuccessful treatment is predicated, in part, on suboptimal adherence with the medication regimen. Motivating long-term compliance remains a challenge. The literature on adherence with rosacea medication is scant, but data from other diseases suggest that a multifactorial approach combining nonpharmacologic and adherence-enhancing pharmacologic interventions appears to offer the greatest success. The variety of topical metronidazole formulations that are relatively well tolerated and convenient to administer has been a notable advance in rosacea management. The dermatologist, by emphasizing the importance of adherence with therapy, can do much to facilitate this most critical behavior.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Meichenbaum D, Turk DC.Facilitating Treatment Adherence: A Practitioner’s Guidebook. New York, NY: Plenum Press; 1987:11–68.

    Google Scholar 

  2. Haynes RB, McKibbin KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications.Lancet. 1996;348:383–386.

    Article  PubMed  CAS  Google Scholar 

  3. DiMatteo MR, Sherbourne CD, Hays RD, et al. Physicians’ characteristics influence patients’ adherence to medical treatment: results from the Medical Outcomes Study.Health Psychol. 1993;12:93–102.

    Article  PubMed  CAS  Google Scholar 

  4. Data on file. Galderma Laboratories LP, Fort Worth, Texas, USA.

  5. Knight AG, Vickers CFH. A follow-up of tetracycline-treated rosacea.Br J Dermatol. 1975;93: 577–580.

    Article  PubMed  CAS  Google Scholar 

  6. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis.Med Care. 1998;36:1138–1161.

    Article  PubMed  CAS  Google Scholar 

  7. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance.Arch Intern Med. 1990;150:1881–1884.

    Article  PubMed  CAS  Google Scholar 

  8. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique.JAMA. 1989;261:3273–3277.

    Article  PubMed  CAS  Google Scholar 

  9. Urquhart J. Controlled drug delivery: therapeutic and pharmacological aspects.J Intern Med. 2000;248:357–376.

    Article  PubMed  CAS  Google Scholar 

  10. Flanders PA, McNamara JR. Enhancing acne medication compliance: a comparison of strategies.Behav Res Ther. 1985;23:225–227.

    Article  PubMed  CAS  Google Scholar 

  11. Katsambas AD. Why and when the treatment of acne fails: what to do.Dermatology. 1998;196: 158–161.

    Article  PubMed  CAS  Google Scholar 

  12. Draelos ZK. Patient compliance: enhancing clinician abilities and strategies.J Am Acad Dermatol. 1995;32(suppl, pt 3):S42-S48.

    Article  PubMed  CAS  Google Scholar 

  13. Shear NH, Levine C. Needs survey of Canadian rosacea patients.J Cutan Med Surg. 1999;3: 178–181.

    PubMed  CAS  Google Scholar 

  14. Cline RJ. Interpersonal communication skills for enhancing physician-patient relationships.Md State Med J. 1983;32:272–278.

    PubMed  CAS  Google Scholar 

  15. Roter D, Frankel R. Quantitative and qualitative approaches to the evaluation of the medical dialogue.Soc Sci Med. 1992;34:1097–1103.

    Article  PubMed  CAS  Google Scholar 

  16. Thiboutot DM. Acne rosacea.Am Fam Physician. 1994;50:1691–1697.

    PubMed  CAS  Google Scholar 

  17. Dahl MV, Katz HI, Krueger GG, et al. Topical metronidazole maintains remissions of rosacea.Arch Dermatol. 1998;134:679–683.

    Article  PubMed  CAS  Google Scholar 

  18. Bleicher PA, Charles JH, Sober AJ. Topical metronidazole therapy for rosacea.Arch Dermatol. 1987;123:609–614.

    Article  PubMed  CAS  Google Scholar 

  19. Aronson IK, Rumsfield JA, West DP, Alexander J, Fischer JH, Paloucek FP. Evaluation of topical metronidazole gel in acne rosacea.Drug Intell Clin Pharm. 1987;21:346–351.

    PubMed  CAS  Google Scholar 

  20. Breneman DL, Stewart D, Hevia O, Hino PD, Drake LA. A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea.Cutis. 1998;61:44–47.

    PubMed  CAS  Google Scholar 

  21. Dahl MV, Jarratt M, Kaplan D, Tuley MR, Baker MD. Once-daily topical metronidazole formulations effectively treat the papules and pustules of rosacea.J Am Acad Dermatol. 2001;45:723–730.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Baylor College of Medicine, Houston, Texas

    John E. Wolf M.D. (Professor and Chairman)

Authors
  1. John E. Wolf M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wolf, J.E. Medication adherence: A key factor in effective management of rosacea. Adv Therapy 18, 272–281 (2001). https://doi.org/10.1007/BF02850197

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02850197

Keywords

Search

Navigation